Emergence of oropharyngeal candidiasis caused by non-albicans species of Candida in HIV-infected patients

scientific article published in July 1993

Emergence of oropharyngeal candidiasis caused by non-albicans species of Candida in HIV-infected patients is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1025001520
P356DOI10.1007/BF00157408
P698PubMed publication ID8243605

P2093author name stringF Barchiesi
G Scalise
V Morbiducci
F Ancarani
P2860cites workIncrease inCandida kruseiInfection among Patients with Bone Marrow Transplantation and Neutropenia Treated Prophylactically with FluconazoleQ43543160
Mucosal candidiasis caused by non-albicans species of Candida in HIV-positive patientsQ44881498
Fluconazole and Candida krusei fungemia.Q54286404
Candida krusei sepsis in HIV infectionQ68016905
P433issue4
P921main subjectcandidiasisQ273510
Candida albicansQ310443
P304page(s)455-456
P577publication date1993-07-01
P1433published inEuropean Journal of EpidemiologyQ5412723
P1476titleEmergence of oropharyngeal candidiasis caused by non-albicans species of Candida in HIV-infected patients
P478volume9

Reverse relations

cites work (P2860)
Q41754780Antifungal therapy in the oral cavity
Q34721925Candida glabrata Esophagitis: Are We Seeing the Emergence of a New Azole-Resistant Pathogen?
Q28264860Echinocandins in the management of invasive fungal infections, Part 2
Q47646968Fluconazole Resistance among Oral Candida Isolates from People Living with HIV/AIDS in a Nigerian Tertiary Hospital
Q58760701Human defects in STAT3 promote oral mucosal fungal and bacterial dysbiosis
Q77931985In vitro activities of antimicrobial agents against Candida species
Q33685839Nosocomial fungal infections: candidemia
Q34633796Optimal management of oropharyngeal and esophageal candidiasis in patients living with HIV infection
Q40827662Options for the management of mucosal candidiasis in patients with AIDS and HIV infection
Q45399634Oral Candida colonization of human immunodeficiency virus infected subjects in Turkey and its relation with viral load and CD4+ T-lymphocyte count
Q34041589Oral Candida isolates colonizing or infecting human immunodeficiency virus-infected and healthy persons in Mexico
Q45050994Oropharyngeal candidiasis in HIV-infected patients under treatment with protease inhibitors
Q46656032Point prevalence, microbiology and antifungal susceptibility patterns of oral Candida isolates colonizing or infecting Mexican HIV/AIDS patients and healthy persons.
Q40188971Posaconazole for the management of mucosal candidiasis
Q73590280Prevalence and antifungal susceptibility of vaginal yeasts in outpatients attending a gynecological center in Ancona, Italy
Q35110522Resistance of Candida species to fluconazole
Q36642964Role of posaconazole in the management of oropharyngeal and esophageal candidiasis
Q36528018Susceptibility testing of fungi: current status of correlation of in vitro data with clinical outcome
Q33788619The use of fluconazole and itraconazole in the treatment of Candida albicans infections: a review

Search more.